Lunai Bioworks
LNAI
16 hedge funds and large institutions have $641K invested in Lunai Bioworks in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 15 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
59% more capital invested
Capital invested by funds: $403K → $641K (+$238K)
0.24% more ownership
Funds ownership: 4.09% → 4.33% (+0.24%)
41% less funds holding
Funds holding: 27 → 16 (-11)
73% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 15
87% less call options, than puts
Call options by funds: $4K | Put options by funds: $31K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$146K |
| 2 |
State Street
Boston,
Massachusetts
|
+$91K |
| 3 |
Jane Street
New York
|
+$65.1K |
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$11.1K |
| 5 |
VF
Virtu Financial
New York
|
+$9.53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
-$41.7K |
| 2 |
Citigroup
New York
|
-$40.8K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$21.4K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$15.2K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$10.2K |
LNAI Hedge Fund Activity: Q2 2026 in Review
16 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q2 2026, worth a combined $641K — up 59% from $403K a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of LNAI and 4 opened new positions — a net loss of 11 holders — while 4 trimmed existing stakes and 7 added.
The largest buyer was Ground Swell Capital, opening a new position worth an estimated $146K. The largest seller was Nine Masts Capital, exiting entirely with an estimated $41.7K sold.
- 16 institutional investors held Lunai Bioworks (LNAI) as of Q2 2026, down from 27 in Q1 2026.
- Funds reported $641K of Lunai Bioworks stock for Q2 2026, up 59% quarter-over-quarter.
- 4 funds opened new Lunai Bioworks positions in Q2 2026 and 15 closed out, a net change of -11 holders.
- The largest Lunai Bioworks buyer in Q2 2026 was Ground Swell Capital, an estimated $146K added.
- The largest Lunai Bioworks seller in Q2 2026 was Nine Masts Capital, an estimated $41.7K sold.
Based on aggregated 13F filings for Q2 2026.